Finance

Lists
Q3 2026 earnings • released • EPS beat +5.57% • Revenue miss -2.61%
See results
CE:NYSE
Celanese Corp
$47.84
-3.84%
(-1.91) 1D
$47.84
0.00% (0.00)
After hours
Closed: Nov 5, 4:00:04 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CE...
Open
$50.20
High
$51.59
Low
$47.49
Mkt. cap
5.25B
Avg. vol.
1.59M
Volume
0.00
Dividend
0.25%
Quarterly dividend
$0.03
Ex-dividend date
Oct 27, 2026
P/E ratio
20.11
52-wk high
$70.70
52-wk low
$35.13
EPS
$2.38
Beta
0.72
Shares outstanding
109.75M
No. of employees
11K
Open
$50.20
High
$51.59
Low
$47.49
Mkt. cap
5.25B
Avg. vol.
1.59M
Volume
0.00
Dividend
0.25%
Quarterly dividend
$0.03
Ex-dividend date
Oct 27, 2026
P/E ratio
20.11
52-wk high
$70.70
52-wk low
$35.13
EPS
$2.38
Beta
0.72
Shares outstanding
109.75M
No. of employees
11K
News stories
From web sources and news partners
Profile
Celanese Corporation, formerly known as Hoechst Celanese, is an American technology and specialty materials company headquartered in Irving, Texas. It is a Fortune 500 corporation. The company is the world's leading producer of acetic acid, producing about 1.95 million tonnes per year, representing approximately 20% of global production. Celanese is also the world's largest producer of vinyl acetate monomer. Celanese operates 25 production plants and six research centers in 11 countries, mainly in North America, Europe, and Asia. The company owns and operates the world's three largest acetic acid plants: one in the Clear Lake area of Pasadena, Texas, one on Jurong Island in Singapore, and a third in Nanjing, China. Wikipedia
About Celanese Corp
CEOScott Richardson
Employees11K
Founded1918
HeadquartersIrving, Texas, United States
SectorMaterials
IndustrySpeciality chemicals
Websitecelanese.com
Analyst ratings
Based on 11 analysts giving stock ratings to CE in the past 3 months
Buy
Buy
6
Hold
5
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for CE in the last 3 months.
Highest
Current $47.84
$77.00 (+60.95%)
Average
$60.00 (+25.42%)
Lowest
$46.00 (-3.85%)
Analyst
Recommendation
Action
Price target
Projected
Date
Abigail Eberts
Wells Fargo
Buy
Maintained
$60.00
+25.4%
11/05/2026
Patrick Cunningham
Citi
Buy
Maintained
$65.00
+35.9%
11/04/2026
Jeffrey Zekauskas
J.P. Morgan
Buy
Maintained
$77.00
+61%
11/04/2026
Aleksey Yefremov
Barclays
Hold
Maintained
$57.00
+19.1%
11/04/2026
Matthew DeYoe
Bank of America Securities
Buy
Maintained
$66.00
+38%
11/04/2026
John McNulty
BMO Capital
Hold
Maintained
$56.00
+17.1%
11/02/2026
John Roberts CFA
Mizuho Securities
Hold
Maintained
$53.00
+10.8%
11/03/2026
Vincent Andrews
Morgan Stanley
Hold
Maintained
$58.00
+21.2%
11/02/2026
Arun Viswanathan
RBC Capital
Hold
Maintained
$46.00
-3.8%
10/13/2026
Michael Leithead
Barclays
Hold
Initiated
$49.00
+2.4%
10/12/2026
Unknown Analyst
KeyBanc
Buy
Initiated
$57.00
+19.1%
09/11/2026
Salvator Tiano
KeyBanc
Buy
Initiated
$57.00
+19.1%
09/11/2026
Hassan Ahmed
Alembic Global
Buy
Maintained
$65.00
+35.9%
08/26/2026
Unknown Analyst
TD Cowen
Buy
Maintained
$65.00
+35.9%
08/06/2026
David Begleiter
Deutsche Bank
Buy
Maintained
$50.00
+4.5%
08/06/2026
Eric Boyes
Evercore ISI
Hold
Maintained
$68.00
+42.1%
08/06/2026
Unknown Analyst
Deutsche Bank
Buy
Reiterated
$60.00
+25.4%
07/22/2026
Laurence Alexander
Jefferies
Buy
Maintained
$86.00
+79.8%
06/16/2026
Michael Sison
Wells Fargo
Buy
Reiterated
$80.00
+67.2%
05/27/2026
Joshua Spector
UBS
Hold
Maintained
$64.00
+33.8%
04/09/2026
Ghansham Panjabi
Robert W. Baird
Buy
Maintained
$75.00
+56.8%
03/27/2026
Matthew Blair
Tudor Pickering
Buy
Upgraded
-
-
03/09/2026
Kevin McCarthy
Vertical Research
Buy
Upgraded
$60.00
+25.4%
03/09/2026
Last report
Nov 3, 2026
Fiscal period
Q3 2026
$1.65 / $1.56
+5.57%beat
Revenue / Est. (USD)
2.56B / 2.62B
-2.61%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
2.20B
2.34B
2.75B
2.56B
Cost of goods sold
1.77B
1.85B
2.13B
-
Cost of revenue
1.77B
1.85B
2.13B
-
Research and development expenses
32.00M
28.00M
29.00M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
173.00M
221.00M
246.00M
-
Operating expense
245.00M
289.00M
314.00M
-
Total operating expenses
2.02B
2.14B
2.45B
-
Operating income
189.00M
198.00M
304.00M
-
Other non operating income
-
1.00M
-25.00M
-
EBT including unusual items
13.00M
82.00M
142.00M
-
EBT excluding unusual items
102.00M
73.00M
175.00M
-
Income tax expense
-15.00M
33.00M
11.00M
-
Effective tax rate
-115.38%
40.24%
7.75%
-
Other operating expenses
-
-
-
-
Net income
19.00M
44.00M
125.00M
-
Net profit margin
0.86%
1.88%
4.54%
2.90%
Earnings per share
0.67
0.85
2.45
1.65
Interest and investment income
46.00M
10.00M
53.00M
-
Interest expense
-177.00M
-183.00M
-186.00M
-
Net interest expenses
-131.00M
-173.00M
-133.00M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
441.00M
377.00M
527.00M
-
Gain or loss from assets sale
2.00M
-48.00M
1.00M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps